Inhibition of EGFR prevents tumour growth and dissemination as well as inducing cell death (apoptosis). (Source: ABPI)
-
One of several new cancer biotherapies, Erbitux is currently in... -
Inhibition of EGFR prevents tumour growth and dissemination as well as... -
Over expression of EGFR correlates with increased metastasis, decreased... -
Erbitux is a chimaeric monoclonal antibody (MAb) specific for the EGFR. -
Erbitux has been approved for use in metastatic colorectal cancer in both... -
In July 2002, ImClone Systems secured FDA approval for the production of...
